Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvedBy |
2010 (US)
|
| gptkbp:ATCCode |
A16AA05
|
| gptkbp:brand |
gptkb:Carbaglu
|
| gptkbp:CASNumber |
349631-97-8
|
| gptkbp:contraindication |
hypersensitivity to carglumic acid
|
| gptkbp:discoveredBy |
gptkb:Orphan_Europe
|
| gptkbp:hasMolecularFormula |
C6H10N2O5
|
| https://www.w3.org/2000/01/rdf-schema#label |
carglumic acid
|
| gptkbp:KEGGID |
D03675
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
activates carbamoyl phosphate synthetase I
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
CHEMBL1201192
140995 DB00673 160441 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
fever
vomiting diarrhea abdominal pain |
| gptkbp:status |
FDA approved
EMA approved |
| gptkbp:UNII |
3KX376GY7L
|
| gptkbp:usedFor |
treatment of hyperammonemia
treatment of N-acetylglutamate synthase deficiency |
| gptkbp:bfsParent |
gptkb:Carbaglu
|
| gptkbp:bfsLayer |
8
|